Pharm Tech Minutes 2021.02.05

From IHE Wiki
Revision as of 09:36, 5 February 2021 by Michael tan (talk | contribs) (→‎F2F)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Minutes =
Link to Microsoft Teams
Teams

Welcome

  • Participants
    • Jose Costa Teixeira
    • Michael Tan
    • Hans Lunenborg
    • Stephane Spahni
    • Leonidas Tzimis


  • Review and Approve Agenda
  • Review minutes previous meetings:

https://wiki.ihe.net/index.php/Pharm_Tech_Minutes_2021.01.08

F2F

  • Will organize a video conference instead of face to face meeting in March.
  • Settled on 2 afternoon's on 16 and 17 th of March
  • Organize 2 x 1,5 hour for each session
  • Michael will set up an initial proposal for the meetings
  • The schedule has been updated and can be found here.

Documentation

  • No consensus with John Moerkhe about the documentation method of IHE.
  • According to John their is no planning from IHE.
  • Who should make the decision. Topic for DCC? How do we manage the plan.
  • Jose to carry the topic to DCC.

Medication List

  • HL7 Pharmacy is also running a topic called Active Medication lists.
  • Jose is working with Belgian insurance company about a medication list architecture. The information can be found here:

http://build.fhir.org/ig/hl7-be/hl7-be-fhir-medication/branches/master/StructureDefinition-be-model-medication-record.html

  • No contact with Oliver Egger. Stephane to contact Oliver.

Vaccination

  • Stephane mentioned that IHE Gemini already has a topic on inquiring a vaccination. See:

https://www.ihe.net/news/ihe-continues-to-pave-the-way-for-fhir-through-project-gemini/ and http://blog.hl7.org/another_type_of_moonshotproject_gemini

  • Serious interest from DCC. Chris Carr arranged an interview with Carrie Pallardy with the purpose of recruiting other sponsors.
  • Looking for funding and interested parties.
  • Meanwhile the biweekly calls will carry on with modelling work on the content.

Any other business

Pharmacy Technical Committee